It appears that Big Pharma has an unlimited number of tricks up its sleeve. From millions and millions of dollars poured into the pockets of regulators and politicians to the subsidization of medical schools and the doctors they churn out, Big Pharma is a force to be reckoned with. However, recently Big Pharma has engaged in a battle plan that few would have expected — an attack on Little Pharma.
In an article published by Techdirt, Dave Fuchs points out that more and more patents held by Big Pharma are beginning to run out. What this means is that Little Pharma may now make generic versions of the same drug and place them on the market at a much lower price. Aside from the fact that the vast majority (if not all) of these drugs are toxic and harmful, the good news is that for those people who consume them the price will go down.
At least, the price is supposed to go down.
That’s where Big Pharma and its sister organization, the FDA, come in. Actually, in this case, the ball is in the FDA’s court. That’s why, in 2010, the FDA removed close to 500 generic drugs off the market.
Of course, we should all bear in mind that removing these drugs only hurts Little Pharma, since Big Pharma can continue making the previously patented drug at enormous profits. However, while Big Pharma no longer has the patent process to protect their business interests, it now has something almost as good — the absence of Little Pharma.
After all, competition is a sin from the point of view of major international corporations including those that make the toxic cocktails we now call medicine. If you can’t patent your way into a monopoly, simply run the competition out of town.
Regardless, with Big Pharma now in control of virtually the entire market, they are able to maintain and raise their prices at will. Certainly, this will come in handy once ObamaCare comes into full effect.
As every American is forced to buy private insurance complete with death panels and “cost-effective” measures, there is no doubt that Big Pharma will continue to raise the prices of its drugs. One can already hear the chorus of government bureaucrats, talking heads, and bioethicists who will be screaming that the insurance we were forced to buy can no longer afford the expensive medicines that no longer exist in generic form.
In the end, the removal of these drugs from the market is not a victory for consumer safety, nor is it a victory for the natural supplement industry. The FDA did not come to the rescue of the American consumer, it came to the rescue of Big Pharma.
Is anyone surprised?
Brandon Turbeville is an author out of Mullins, South Carolina. He has a Bachelor’s Degree from Francis Marion University where he earned the Pee Dee Electric Scholar’s Award as an undergraduate. He has had numerous articles published dealing with a wide variety of subjects including health, economics, and civil liberties. He also the author of Codex Alimentarius – The End of Health Freedom